| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 7.34e-05 | 120 | 14 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.79e-04 | 430 | 14 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 3.32e-04 | 200 | 14 | 3 | GO:0008237 | |
| GeneOntologyMolecularFunction | peptidase activity | 8.78e-04 | 654 | 14 | 4 | GO:0008233 | |
| GeneOntologyMolecularFunction | amide binding | 1.07e-03 | 299 | 14 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.26e-03 | 102 | 14 | 2 | GO:0001540 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 3.54e-06 | 49 | 13 | 3 | GO:1904646 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 6.89e-06 | 61 | 13 | 3 | GO:1904645 | |
| GeneOntologyBiologicalProcess | positive regulation of axon regeneration | 4.96e-05 | 17 | 13 | 2 | GO:0048680 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 5.58e-05 | 18 | 13 | 2 | GO:0070572 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 6.89e-05 | 377 | 13 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 6.96e-05 | 378 | 13 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 7.04e-05 | 379 | 13 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | transcytosis | 1.00e-04 | 24 | 13 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 2.82e-04 | 40 | 13 | 2 | GO:0048679 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.82e-04 | 40 | 13 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 2.84e-04 | 212 | 13 | 3 | GO:0003205 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.97e-04 | 41 | 13 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 3.90e-04 | 47 | 13 | 2 | GO:0070570 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 7.01e-04 | 63 | 13 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 7.02e-04 | 289 | 13 | 3 | GO:0000209 | |
| GeneOntologyBiologicalProcess | axon regeneration | 8.40e-04 | 69 | 13 | 2 | GO:0031103 | |
| GeneOntologyBiologicalProcess | heart development | 9.87e-04 | 757 | 13 | 4 | GO:0007507 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.07e-03 | 78 | 13 | 2 | GO:0003170 | |
| GeneOntologyBiologicalProcess | aorta development | 1.13e-03 | 80 | 13 | 2 | GO:0035904 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 1.16e-03 | 81 | 13 | 2 | GO:0031102 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.33e-03 | 1442 | 13 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.49e-03 | 92 | 13 | 2 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 1.52e-03 | 93 | 13 | 2 | GO:1903036 | |
| GeneOntologyBiologicalProcess | response to axon injury | 1.93e-03 | 105 | 13 | 2 | GO:0048678 | |
| Domain | ADAM_spacer1 | 5.89e-07 | 23 | 14 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 5.89e-07 | 23 | 14 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 6.72e-07 | 24 | 14 | 3 | IPR013273 | |
| Domain | Pep_M12B_propep | 3.02e-06 | 39 | 14 | 3 | PF01562 | |
| Domain | Peptidase_M12B_N | 3.02e-06 | 39 | 14 | 3 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 3.26e-06 | 40 | 14 | 3 | PS00427 | |
| Domain | Reprolysin | 3.26e-06 | 40 | 14 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.26e-06 | 40 | 14 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.26e-06 | 40 | 14 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.26e-06 | 40 | 14 | 3 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 3.51e-06 | 41 | 14 | 3 | PS00546 | |
| Domain | Disintegrin_dom | 3.51e-06 | 41 | 14 | 3 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 4.07e-06 | 43 | 14 | 3 | IPR001818 | |
| Domain | TSP_1 | 1.30e-05 | 63 | 14 | 3 | PF00090 | |
| Domain | TSP1_rpt | 1.42e-05 | 65 | 14 | 3 | IPR000884 | |
| Domain | TSP1 | 1.42e-05 | 65 | 14 | 3 | PS50092 | |
| Domain | TSP1 | 1.42e-05 | 65 | 14 | 3 | SM00209 | |
| Domain | - | 2.76e-05 | 81 | 14 | 3 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.76e-05 | 81 | 14 | 3 | IPR024079 | |
| Domain | PLAC | 4.72e-05 | 14 | 14 | 2 | PF08686 | |
| Domain | ZINC_PROTEASE | 4.89e-05 | 98 | 14 | 3 | PS00142 | |
| Domain | PLAC | 8.86e-05 | 19 | 14 | 2 | IPR010909 | |
| Domain | PLAC | 8.86e-05 | 19 | 14 | 2 | PS50900 | |
| Domain | ADAM_Cys-rich | 1.81e-04 | 27 | 14 | 2 | IPR006586 | |
| Domain | ACR | 1.81e-04 | 27 | 14 | 2 | SM00608 | |
| Domain | Growth_fac_rcpt_ | 5.91e-03 | 156 | 14 | 2 | IPR009030 | |
| Domain | Znf_C3HC4_RING-type | 7.13e-03 | 172 | 14 | 2 | IPR018957 | |
| Domain | zf-C3HC4 | 1.18e-02 | 223 | 14 | 2 | PF00097 | |
| Domain | ZF_RING_2 | 2.03e-02 | 298 | 14 | 2 | PS50089 | |
| Domain | RING | 2.13e-02 | 305 | 14 | 2 | SM00184 | |
| Domain | Znf_RING | 2.41e-02 | 326 | 14 | 2 | IPR001841 | |
| Domain | L_dom-like | 2.43e-02 | 328 | 14 | 2 | IPR032675 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.18e-06 | 39 | 11 | 3 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.18e-06 | 39 | 11 | 3 | M27417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.72e-05 | 68 | 11 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.09e-05 | 109 | 11 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.49e-05 | 111 | 11 | 3 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.59e-04 | 143 | 11 | 3 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.18e-04 | 250 | 11 | 3 | M27554 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.45e-03 | 74 | 11 | 2 | MM15962 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 15749709 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 20685197 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 19251705 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 23926111 | ||
| Pubmed | 3.16e-06 | 7 | 14 | 2 | 11867212 | ||
| Pubmed | 3.16e-06 | 7 | 14 | 2 | 17920016 | ||
| Pubmed | 3.45e-06 | 75 | 14 | 3 | 20637190 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 9.91e-06 | 12 | 14 | 2 | 25770910 | |
| Pubmed | 1.58e-05 | 15 | 14 | 2 | 20468060 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 2.29e-05 | 18 | 14 | 2 | 35503090 | |
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 7.21e-05 | 207 | 14 | 3 | 26238476 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.68e-04 | 736 | 14 | 4 | 29676528 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 1.76e-03 | 206 | 14 | 2 | chr15q26 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.23e-08 | 19 | 9 | 3 | 50 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.54e-02 | 394 | 9 | 2 | 471 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.91e-06 | 212 | 14 | 4 | M39221 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON | 6.08e-05 | 22 | 14 | 2 | M1352 | |
| Coexpression | GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP | 1.33e-04 | 192 | 14 | 3 | M5665 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.50e-04 | 200 | 14 | 3 | M6477 | |
| Coexpression | NABA_ECM_REGULATORS | 2.50e-04 | 238 | 14 | 3 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.62e-04 | 242 | 14 | 3 | MM17062 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 4.98e-05 | 357 | 13 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.46e-05 | 125 | 13 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 6.37e-05 | 773 | 13 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 6.77e-05 | 783 | 13 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 6.89e-05 | 388 | 13 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.24e-04 | 165 | 13 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.53e-04 | 210 | 13 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.44e-04 | 233 | 13 | 3 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#1 | 3.68e-04 | 47 | 13 | 2 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.28e-04 | 251 | 13 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 5.42e-04 | 57 | 13 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.71e-04 | 293 | 13 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.26e-04 | 301 | 13 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 8.13e-04 | 740 | 13 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_100 | 8.63e-04 | 72 | 13 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 9.72e-04 | 776 | 13 | 4 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 9.76e-04 | 777 | 13 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 9.81e-04 | 778 | 13 | 4 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.01e-03 | 78 | 13 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.06e-03 | 795 | 13 | 4 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 1.07e-03 | 797 | 13 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.10e-03 | 803 | 13 | 4 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.14e-03 | 83 | 13 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.18e-03 | 356 | 13 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.26e-03 | 364 | 13 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_100 | 1.29e-03 | 88 | 13 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.34e-03 | 372 | 13 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.47e-03 | 94 | 13 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.56e-03 | 97 | 13 | 2 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.49e-05 | 187 | 14 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.49e-05 | 187 | 14 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.53e-05 | 188 | 14 | 3 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.95e-05 | 198 | 14 | 3 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-05 | 200 | 14 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 7.04e-04 | 127 | 14 | 2 | df2854bcb2708ddc13b3ca48c03887380e827790 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.18e-04 | 137 | 14 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.00e-03 | 152 | 14 | 2 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 155 | 14 | 2 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 155 | 14 | 2 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-03 | 155 | 14 | 2 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.06e-03 | 156 | 14 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-03 | 159 | 14 | 2 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-03 | 161 | 14 | 2 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-03 | 162 | 14 | 2 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-03 | 162 | 14 | 2 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.15e-03 | 163 | 14 | 2 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.17e-03 | 164 | 14 | 2 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 1.18e-03 | 165 | 14 | 2 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-03 | 166 | 14 | 2 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-03 | 166 | 14 | 2 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-03 | 166 | 14 | 2 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-03 | 166 | 14 | 2 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-03 | 166 | 14 | 2 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-03 | 166 | 14 | 2 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-03 | 167 | 14 | 2 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.25e-03 | 170 | 14 | 2 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.25e-03 | 170 | 14 | 2 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-03 | 171 | 14 | 2 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-03 | 172 | 14 | 2 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.28e-03 | 172 | 14 | 2 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 1.28e-03 | 172 | 14 | 2 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.30e-03 | 173 | 14 | 2 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.30e-03 | 173 | 14 | 2 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-03 | 174 | 14 | 2 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-03 | 174 | 14 | 2 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-03 | 176 | 14 | 2 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.34e-03 | 176 | 14 | 2 | 9c1f255de3082b3da4bef2a9bdff710cfd48261f | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.34e-03 | 176 | 14 | 2 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.34e-03 | 176 | 14 | 2 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 1.34e-03 | 176 | 14 | 2 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-03 | 176 | 14 | 2 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 177 | 14 | 2 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-03 | 177 | 14 | 2 | 01df8ab3285fa66b4805c555cfbfc4b3b16db919 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.36e-03 | 177 | 14 | 2 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.36e-03 | 177 | 14 | 2 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-03 | 178 | 14 | 2 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.37e-03 | 178 | 14 | 2 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 178 | 14 | 2 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-03 | 178 | 14 | 2 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.39e-03 | 179 | 14 | 2 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-03 | 179 | 14 | 2 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-03 | 179 | 14 | 2 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.39e-03 | 179 | 14 | 2 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-03 | 180 | 14 | 2 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.42e-03 | 181 | 14 | 2 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.43e-03 | 182 | 14 | 2 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-03 | 182 | 14 | 2 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 182 | 14 | 2 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 182 | 14 | 2 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-03 | 182 | 14 | 2 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-03 | 183 | 14 | 2 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-03 | 183 | 14 | 2 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.45e-03 | 183 | 14 | 2 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-03 | 183 | 14 | 2 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-03 | 183 | 14 | 2 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-03 | 183 | 14 | 2 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.45e-03 | 183 | 14 | 2 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-03 | 183 | 14 | 2 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.47e-03 | 184 | 14 | 2 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-03 | 184 | 14 | 2 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.47e-03 | 184 | 14 | 2 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.47e-03 | 184 | 14 | 2 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-03 | 185 | 14 | 2 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 185 | 14 | 2 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.48e-03 | 185 | 14 | 2 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-03 | 185 | 14 | 2 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.48e-03 | 185 | 14 | 2 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-03 | 185 | 14 | 2 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 185 | 14 | 2 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-03 | 185 | 14 | 2 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-03 | 185 | 14 | 2 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 185 | 14 | 2 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-03 | 185 | 14 | 2 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-03 | 185 | 14 | 2 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-03 | 185 | 14 | 2 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.48e-03 | 185 | 14 | 2 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-03 | 185 | 14 | 2 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 186 | 14 | 2 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 186 | 14 | 2 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 186 | 14 | 2 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-03 | 186 | 14 | 2 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.50e-03 | 186 | 14 | 2 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.50e-03 | 186 | 14 | 2 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-03 | 186 | 14 | 2 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 1.50e-03 | 186 | 14 | 2 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 187 | 14 | 2 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-03 | 187 | 14 | 2 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 187 | 14 | 2 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.51e-03 | 187 | 14 | 2 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| Drug | tegafur | 3.35e-06 | 49 | 14 | 3 | CID000005386 | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 4.78e-06 | 194 | 14 | 4 | 2299_UP | |
| Drug | valinomycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.63e-04 | 179 | 14 | 3 | 5962_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.77e-04 | 184 | 14 | 3 | 2185_UP | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; HL60; HT_HG-U133A | 1.80e-04 | 185 | 14 | 3 | 2916_UP | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.95e-04 | 190 | 14 | 3 | 4307_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 6660_DN | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; PC3; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 3992_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 7300_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 4758_UP | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2308_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3744_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 3294_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2492_UP | |
| Drug | novobiocin sodium, USP; Up 200; 100uM; SKMEL5; HG-U133A | 2.20e-04 | 198 | 14 | 3 | 632_UP | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 7386_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4273_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4353_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2197_UP | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5104_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5087_UP | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 4166_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 1488_UP | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 6665_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3226_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3966_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3668_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3274_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 3825_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 3713_DN | |
| Drug | TSPP | 5.50e-04 | 57 | 14 | 2 | CID000024403 | |
| Drug | Hypochlorous Acid | 1.54e-03 | 387 | 14 | 3 | ctd:D006997 | |
| Drug | Isoflurane | 1.81e-03 | 104 | 14 | 2 | ctd:D007530 | |
| Drug | MNPA | 2.52e-03 | 123 | 14 | 2 | CID000001301 | |
| Drug | Linuron | 2.73e-03 | 128 | 14 | 2 | ctd:D008044 | |
| Drug | CAS 68-19-9 | 3.49e-03 | 145 | 14 | 2 | CID000002891 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 2.58e-06 | 58 | 14 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 6.75e-05 | 26 | 14 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Moyamoya disease | 1.61e-04 | 40 | 14 | 2 | MONDO_0016820 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.29e-04 | 57 | 14 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | Headache | 4.14e-04 | 64 | 14 | 2 | HP_0002315 | |
| Disease | migraine disorder, Headache | 7.47e-04 | 86 | 14 | 2 | HP_0002315, MONDO_0005277 | |
| Disease | Acute Confusional Senile Dementia | 9.88e-04 | 99 | 14 | 2 | C0546126 | |
| Disease | Presenile dementia | 9.88e-04 | 99 | 14 | 2 | C0011265 | |
| Disease | Alzheimer's Disease, Focal Onset | 9.88e-04 | 99 | 14 | 2 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 9.88e-04 | 99 | 14 | 2 | C0750901 | |
| Disease | Alzheimer Disease, Late Onset | 9.88e-04 | 99 | 14 | 2 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.01e-03 | 100 | 14 | 2 | C0276496 | |
| Disease | Alzheimer's Disease | 1.03e-03 | 101 | 14 | 2 | C0002395 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.11e-03 | 105 | 14 | 2 | DOID:9352 (implicated_via_orthology) | |
| Disease | cortical thickness | 1.49e-03 | 1113 | 14 | 4 | EFO_0004840 | |
| Disease | peak expiratory flow | 1.51e-03 | 498 | 14 | 3 | EFO_0009718 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.74e-03 | 132 | 14 | 2 | DOID:10652 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 2.01e-03 | 550 | 14 | 3 | EFO_0004346, EFO_0004464 | |
| Disease | obesity (biomarker_via_orthology) | 2.16e-03 | 147 | 14 | 2 | DOID:9970 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 2.42e-03 | 156 | 14 | 2 | DOID:10283 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVCQWRCLRCLRQQH | 476 | P56817 | |
| NLQRCCWNRHISSCM | 41 | Q5VTE6 | |
| LCQDMRWYQRCCQTC | 1066 | Q8TE56 | |
| LCQDMRWYQRCCETC | 1181 | Q8TE59 | |
| LQCRQCDRWMHAVCQ | 1101 | Q8NEZ4 | |
| RQCSNGRCVSNMLWC | 2571 | Q07954 | |
| YNYRCWTTNRCQKMC | 201 | P08069 | |
| LQSCIRMWQCRQCYR | 96 | P0C7M6 | |
| RMWQCRQCYRQMCNA | 101 | P0C7M6 | |
| VCPYMMQCRRLWCNN | 531 | Q9P2N4 | |
| TNQLCRCARVCRRWY | 131 | Q9UJT9 | |
| TLRCMLGRVYQRCWQ | 71 | Q9BQD1 | |
| MASVQASRRQWCYLC | 1 | Q8IU81 | |
| NCVMSRKQRNRCQYC | 101 | Q15406 | |
| SWRLYLVNLCQRCMD | 671 | Q63HN8 |